# Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes

> **NCT03113773** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 41 (actual)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** Proleukin
- **DRUG:** Placebo Injection

## Key facts

- **NCT ID:** NCT03113773
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-11
- **Primary completion:** 2019-02-21
- **Final completion:** 2019-02-21
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113773, "Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03113773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*